 |
||||
|
|
The Office of Technology Management is in contact with a company who is looking to in- license-exclusively or non-exclusively new antibotics. Our company is a pharmaceutical company focused on the development of new antibiotics. We are especially interested in novel compounds for the treatment of serious bacterial infections such as tuberculosis, MRSA, anthrax etc.
Please contact the Office of Technology Management if you have any technology that may be relevant to this request. |
|||
